NASDAQ:KARD Kardigan Q2 2026 Earnings Report $19.68 -1.92 (-8.89%) As of 04:00 PM Eastern ProfileEarnings HistoryForecast Kardigan EPS ResultsActual EPS-$4.61Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AKardigan Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AKardigan Announcement DetailsQuarterQ2 2026Date8/11/2026TimeBefore Market OpensConference Call DateTuesday, August 11, 2026Conference Call Time7:00AM ETConference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Kardigan Earnings HeadlinesKardigan to Present at Two September Investor ConferencesSeptember 2, 2026 | businesswire.comKardigan’s Danicamtiv Heart Study Moves Forward, Keeping KARD on Investors’ RadarSeptember 2, 2026 | tipranks.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.September 9 at 1:00 AM | Stansberry Research (Ad)Kardigan Inc (KARD) Stock Price, Quote, News & HistoryAugust 20, 2026 | benzinga.comWe've developed a first-of-its-kind medicine to battle cardiovascular disease: Kardigan CEOJune 26, 2026 | msn.comHow Kardigan spun deal leftovers into a $400M IPOJune 24, 2026 | finance.yahoo.comSee More Kardigan Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Kardigan? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Kardigan and other key companies, straight to your email. Email Address About KardiganKardigan (NASDAQ:KARD) Inc. is a clinical-stage precision therapeutics company developing medicines which target the root cause of specific cardiovascular diseases. Kardigan Inc. is based in South San Francisco, California.View Kardigan ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Casey’s Post-Earnings Drop May Give Investors a Better Entry Into a Quality RetailerCathie Wood Trimmed Palantir, But the Bigger Story Is Still ValuationIntel’s ASML Milestone Gives Investors a New Reason to Revisit the StockAnalog Devices Shows Why AI Is Not the Only Story Driving Chip DemandDefense, Solar, and Refining Stocks Split as the Iran Conflict Raises Energy RiskLithia’s Record Quarter Keeps the Bull Case AliveLululemon’s Problems May Not Be a Warning for Every Athleticwear Stock Upcoming Earnings Adobe (9/10/2026)Oracle (9/10/2026)Cintas (9/23/2026)Costco Wholesale (9/24/2026)Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/8/2026)America Movil (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
